[ad_1]
Teladoc Health shares
TDOC,
rose 5%, to $23.94, in aftermarket trading Tuesday following its latest quarterly results and current outlook.
The stock, which closed down 2.5%, to $22.78, is down 3.7% on the year.
The telemedicine provider narrowed its loss and grew revenue in the second quarter. Revenue climbed to $652.4 million from $592.4 million in the second quarter.
Teladoc forecast revenue between $650 million and $675 million and a loss per-share between 40 cents and 50 cents for the third quarter. Analysts polled by FactSet expected $663.1 million in revenue and a loss of 33 cents a share.
For the year ending Dec. 31, 2023, it guided for revenue between $2.6 billion and $2.68 billion and loss per-share in the range of $1.25 and $1.60. It previously forecast revenue between $2.58 billion and $2.68 billion and a loss between $1.25 a share and $1.70 a share.
[ad_2]
Source link
